Company: AEMD
Filing Date: 2025-09-10
Form Type: SCHEDULE 13G
Source: 0001213900-25-086628
Chunk: 0

Company: AETHLON MEDICAL INC
Filing Date: 2025-09-10
Form: SCHEDULE 13G
Chunk 0
---
 Intracoastal at the closing of the transaction contemplated by the SPA ("Intracoastal Warrant 1"), and all such shares of Common Stock represent beneficial ownership of approximately 9.99% of the Common Stock, based on (1) 2,598,711 shares of Common Stock outstanding as of September 3, 2025, as reported by the Issuer, plus (2) 280,000 shares of Common Stock to be issued to Intracoastal at the closing of the transaction contemplated by the SPA and (3) 8,424 shares of Common Stock issuable upon exercise of Intracoastal Warrant 1. The foregoing excludes (I) 267,131 shares of Common Stock issuable upon exercise of Intracoastal Warrant 1 because Intracoastal Warrant 1 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 1 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 9.99% of the Common Stock and (II) 555,555 shares of Common Stock issuable upon exercise of a second warrant to be issued to Intracoastal at the closing of the transaction contemplated by the SPA ("Intracoastal Warrant 2") because Intracoastal Warrant 2 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 2 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 9.99% of the Common Stock. Without such blocker provisions, each of the Reporting Persons may have been deemed to have beneficial ownership of 1,111,110 shares of Common Stock. 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    (ii)  As of the close of business on September 10, 2025, each of the Reporting Persons may have been deemed to have beneficial ownership of 576,603 shares of Common Stock, which consisted of (i) 21,048 shares of Common Stock held by Intracoastal and (ii